| Literature DB >> 18671876 |
Paluku Bahwere1, Ellen Piwoz, Marthias C Joshua, Kate Sadler, Caroline H Grobler-Tanner, Saul Guerrero, Steve Collins.
Abstract
BACKGROUND: In Malawi and other high HIV prevalence countries, studies suggest that more than 30% of all severely malnourished children admitted to inpatient nutrition rehabilitation units are HIV-infected. However, clinical algorithms designed to diagnose paediatric HIV are neither sensitive nor specific in severely malnourished children. The present study was conducted to assess : i) whether HIV testing can be integrated into Community-based Therapeutic Care (CTC); ii) to determine if CTC can improve the identification of HIV infected children; and iii) to assess the impact of CTC programmes on the rehabilitation of HIV-infected children with Severe Acute Malnutrition (SAM).Entities:
Mesh:
Year: 2008 PMID: 18671876 PMCID: PMC2536666 DOI: 10.1186/1471-2334-8-106
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Clinical algorithms for diagnosing paediatric HIV
| • Chest infection requiring hospital admission in the past 3 months | • Weight below 3rd centile | • Classify as suspected symptomatic HIV infection if 3 positive findings | |
| • > = 2 episodes of diarrhea in the past 3 months | • Poor weight gain (growth monitoring card) | ||
| • Episode of persistent diarrhea (lasting 14 days) in the past 3 months | • Any enlarged lymph glands in more than one of the following sites: neck, axillary or groin | ||
| • Fever > = 1 month | • Oral thrush extending to the back of the mouth or throat | ||
| • Poor appetite | |||
| • Chronic ear infection (14 days) | |||
| • History or evidence of past or present herpes zoster | |||
| • History or evidence of severe seborrheic dermatitis | |||
| • History of past or present TB | |||
| • Parent or sibling known to have TB | |||
| • Parent or sibling known to be HIV-positive | |||
| • Pneumonia today§ | • Weight below 3rd centile | • Classify as suspected symptomatic HIV infection if 3 positive findings | |
| • History of weight loss¶ | • Poor weight gain (history or RTH card) | ||
| • Persistent diarrhea now or in past 3 months | • Any enlarged lymph glands in more than one of the following; neck, axillae or groin | ||
| • Ear discharge now or in the past | • Oral thrush | ||
| • Parotid swelling | |||
| • Ear discharge now or in the past | • When child presents with > = 3 criteria refer for further HIV support/care and health education | ||
| • Enlarged lymph glands now | |||
| • Pneumonia today or persistent cough > 1 month | |||
| • Persistent diarrhea | |||
| • Low weight gain¶ | |||
| • Oral thrush | |||
| • Marasmus or Marasmus/Kwashiokor | |||
| • Fever for more than one month | |||
| • Child is an orphan (one or both parents) | |||
| • Child's parents are sick or one of siblings has died | |||
† IMCI = integrated management of childhood illness § Pneumonia was ascertained by asking if the child had breathing abnormalities (fast breathing, chest in-drawing or nasal flaring) and/or severe cough. ¶ All children were assumed to have a history of weight loss/low weight gain.
Figure 1Description of the retrospective cohort.
Baseline characteristics of participants in the retrospective and prospective cohorts
| Accepted VCT | 714 | 97.1 | 1174 | 92.2 | 1888 | 94.0 | ||
| Refused VCT | 21 | 2.9 | 99 | 7.8 | 120 | 6.0 | ||
| 735 | 100.0 | 1273 | 100.0 | 2008 | 100.0 | |||
| Parent and child tested | 471 | 66.0 | 743 | 63.3 | 1214 | 64.3 | ||
| Only child tested | 243 | 34.0 | 431 | 36.7 | 674 | 35.7 | ||
| Orphan (1 or both parents dead) | 35 | 5.0 | 100 | 8.6 | 135 | 7.3 | ||
| Both parents alive | 661 | 95.0 | 1065 | 91.4 | 1726 | 92.7 | ||
| 696 | 100.0 | 1165 | 100.0 | 1861 | 100.0 | |||
| Yes | 65 | 9.1 | 127 | 19.1 | 192 | 13.9 | ||
| No | 648 | 90.9 | 539 | 80.9 | 1187 | 86.1 | ||
| 713 | 100.0 | 666 | 100.0 | 1379 | 100.0 | |||
| Female | 353 | 49.4 | 595 | 52.4 | 948 | 51.3 | ||
| Male | 361 | 50.6 | 540 | 47.6 | 901 | 48.7 | ||
| 714 | 100.0 | 1135 | 100.0 | 1849 | 100.0 | |||
| < 12 | 62 | 10.5 | 157 | 16.8 | 219 | 14.4 | ||
| 12-<24 | 272 | 46.1 | 354 | 37.9 | 626 | 41.1 | ||
| 24-<36 | 153 | 25.9 | 275 | 29.5 | 428 | 28.1 | ||
| > = 36 | 103 | 17.5 | 147 | 15.8 | 250 | 16.4 | ||
| 590 | 100.0 | 933 | 100.0 | 1523 | 100.0 | |||
| Oedema | 597 | 83.7 | 659 | 67.4 | 1256 | 74.3 | ||
| Maramus | 51 | 7.2 | 160 | 16.4 | 211 | 12.5 | ||
| MUAC < 110 mm | 46 | 6.5 | 75 | 7.7 | 121 | 7.2 | ||
| Other criteria | 19 | 2.7 | 84 | 8.6 | 103 | 6.1 | ||
| 713 | 100.0 | 978 | 100.0 | 1691 | 100.0 | |||
| Yes | 597 | 83.7 | 659 | 67.4 | 1256 | 74.3 | ||
| No | 116 | 16.3 | 319 | 32.6 | 435 | 25.7 | ||
| 713 | 100.0 | 978 | 100.0 | 1691 | 100.0 | |||
| 83.3(13.0) | 84.2(14.4) | |||||||
| > = 80 | 397 | 58.7 | 552 | 59.9 | 949 | 59.4 | ||
| 70 to < 80% | 187 | 27.6 | 186 | 20.2 | 373 | 23.3 | ||
| < 70% | 93 | 13.7 | 183 | 19.9 | 276 | 17.3 | ||
| 677 | 100.0 | 921 | 100.0 | 1598 | 100.0 | |||
| 118.0(16.9) | 119.2(18.9) | |||||||
| > = 125 mm | 219 | 34.9 | 326 | 42.0 | 545 | 38.8 | ||
| 110 to < 125 mm | 223 | 35.5 | 208 | 26.8 | 431 | 30.7 | ||
| < 110 mm | 186 | 29.6 | 242 | 31.2 | 428 | 30.5 | ||
| 628 | 100.0 | 776 | 100.0 | 1404 | 100.0 | |||
Demographic characteristics, tuberculosis history and nutrition admission criteria according to the HIV status of children from retrospective and prospective cohorts.
| Female | 12 | 54.5 | 341 | 49.3 | 15 | 53.6 | 580 | 52.4 | ||
| Male | 10 | 45.5 | 351 | 50.7 | 0.626 | 13 | 46.4 | 527 | 47.6 | 0.902 |
| 22 | 100.0 | 692 | 100.0 | 28 | 100.0 | 1107 | 100.0 | |||
| < 12 | 5 | 25.0 | 57 | 10.0 | 4 | 16.0 | 153 | 16.9 | ||
| 12-<24 | 6 | 30.0 | 266 | 46.7 | 9 | 36.0 | 345 | 38.0 | ||
| 24-<36 | 4 | 20.0 | 149 | 26.1 | 0.099 | 8 | 32.0 | 267 | 29.4 | 0.993 |
| > = 36 | 5 | 25.0 | 98 | 17.2 | 4 | 16.0 | 143 | 15.7 | ||
| 20 | 100.0 | 570 | 100.0 | 25 | 100.0 | 908 | 100.0 | |||
| Orphan (1 or both parents) | 7 | 31.8 | 28 | 4.2 | 10 | 34.5 | 90 | 7.9 | ||
| Parents alive | 15 | 68.2 | 646 | 95.8 | < 0.001 | 19 | 65.5 | 1046 | 92.1 | < 0.001 |
| 22 | 100.0 | 674 | 100.0 | 29 | 100.0 | 1136 | 100.0 | |||
| > = 1 proxy present | 14 | 66.7 | 138 | 21.5 | 15 | 53.6 | 261 | 23.9 | ||
| None | 7 | 33.3 | 505 | 78.5 | < 0.001 | 13 | 46.4 | 832 | 76.1 | < 0.001 |
| 21 | 100.0 | 643 | 100.0 | 28 | 100.0 | 1093 | 100.0 | |||
| Yes | 4 | 19.0 | 54 | 8.0 | 7 | 29.2 | 120 | 18.7 | ||
| No | 17 | 81.0 | 621 | 92.0 | 0.089 | 17 | 70.8 | 522 | 81.3 | 0.193 |
| 21 | 675 | 100.0 | 24 | 100.0 | 642 | 100.0 | ||||
| oedema | 14 | 63.6 | 583 | 84.4 | 16 | 55.2 | 643 | 67.8 | ||
| No oedema | 8 | 36.4 | 108 | 15.6 | 0.017 | 13 | 44.8 | 306 | 32.2 | 0.017 |
| 22 | 100.0 | 691 | 100.0 | 29 | 100.0 | 949 | 100.0 | |||
Nutritional status at enrolment and the impact of CTC in HIV-positive and HIV-negative children
| Oedema | 14 | 63.6 | 583 | 84.4 | 0.017† | ||
| Maramus | 1 | 4.5 | 50 | 7.2 | |||
| MUAC < 110 mm | 5 | 22.7 | 41 | 5.9 | |||
| Others criteria | 2 | 9.2 | 17 | 2.5 | |||
| 22 | 100.0 | 691 | 100.0 | ||||
| 80.5(8.9) | 83.3(12.6) | 0.3 | |||||
| > = 70% | 20 | 90.9 | 564 | 86.1 | 0.755 | ||
| < 70% | 2 | 9.1 | 91 | 13.9 | |||
| 22 | 100.0 | 655 | 100.0 | ||||
| 109.2(16.4) | 118.3(16.9) | 0.025 | |||||
| > = 110 mm | 7 | 38.9 | 435 | 71.3 | 0.003 | ||
| < 110 mm | 11 | 61.1 | 175 | 28.7 | |||
| 18 | 100.0 | 610 | 100.0 | ||||
| Recovered | 13 | 59.1 | 523 | 83.4 | 0.002 | ||
| Defaulted | 5 | 22.7 | 89 | 14.2 | < 0.001 | ||
| Died | 4 | 18.2 | 11 | 1.8 | < 0.001 | ||
| Transfer or still in programme | 4 | 0.7 | - | ||||
| Median weight gain (IQR) | 20 | 2.8 (1.3–3.9) | 614 | 4.7(2.9–6.7) | 0.007 | ||
| Median MUAC change (IQR) | 9 | 0.11(-0.03–0.31) | 361 | 0.21(0.05–0.39) | 0.223 | ||
| Median LoS (IQR) | 20 | 56(36–68) | 622 | 42(28–63) | 0.25 | ||
| Oedema | 16 | 55.2 | 643 | 67.8 | 0.154† | ||
| Marasmus | 6 | 20.7 | 154 | 16.2 | |||
| MUAC < 110 mm | 5 | 17.2 | 70 | 7.4 | |||
| Others criteria‡ | 2 | 6.9 | 82 | 8.6 | |||
| 29 | 100.0 | 949 | 100.0 | ||||
| 81.0(15.7) | 84.3(14.4) | 0.26 | |||||
| > = 70 | 17 | 68.0 | 721 | 80.5 | 0.130 | ||
| < 70% | 8 | 32.0 | 175 | 19.5 | |||
| 25 | 100.0 | 896 | 100.0 | ||||
| Median Weight gain (IQR) | 24 | 2.2 (1.6–4.0) | 880 | 3.1(1.1–5.9) | 0.309 | ||
| Median MUAC change (IQR) | 11 | 0.22(0.01–0.45) | 476 | 0.25(0.03–0.48) | 0.891 | ||
| Median LOS (IQR) | 25 | 63(42–128) | 912 | 42(28–67) | 0.002 | ||
† Comparison % oedematous malnutrition; ‡ others criteria = age above 6 months and weight less than 4 kg, child with visible wasting but not meeting marasmus and MUAC criteria and less than 6 months children.
The prevalence and diagnostic characteristics of proxy indicators and clinical algorithms for identifying HIV infection in severely malnourished children
| From widow headed household | 1.4 | 30.0(7.4–121.6) | 19 | 99.2 | 44.4 | 97.4 | 23.8 | 0.8 |
| Looked after by grand-mother | 4.1 | 4.1(1.1–14.6) | 13.6 | 96.3 | 10.7 | 97.1 | 3.7 | 0.9 |
| Orphan (one or both parents dead) | 5.0 | 10.8(4.1–28.5) | 31.8 | 95.8 | 20 | 97.7 | 7.6 | 0.7 |
| From female headed household | 7.1 | 5.8(2.1–17.2) | 28.6 | 93.6 | 12.8 | 97.6 | 4.5 | 0.8 |
| Child with tuberculosis | 1.4 | 9.2(1.8–47.7) | 10 | 98.8 | 20 | 97.4 | 8.3 | 0.9 |
| Minor muco-cutaneous manifestations | 7.2 | 4.6(1.6–13.2) | 25 | 93.3 | 10 | 97.6 | 3.7 | 0.8 |
| Death of the father | 3.1 | 15.6(4.7–49.9) | 27.3 | 97.6 | 27.3 | 97.6 | 11.4 | 0.7 |
| Age < 12 months or age > 59 months | 13.6 | 3.7(1.4–9.5) | 35 | 85.2 | 8.8 | 97.5 | 2.4 | 0.8 |
| MUAC < 110 mm | 29.6 | 3.5(1.9–10.2) | 61.1 | 71.3 | 5.9 | 98.4 | 2.1 | 0.5 |
| Absence of oedema | 17.1 | 2.9(1.1–7.7) | 36.4 | 83.7 | 8.3 | 93 | 2.2 | 0.8 |
| Axillary nodes enlargement | 4.8 | 6.7(1.7–26.4) | 23.1 | 95.7 | 13.6 | 97.7 | 5.4 | 0.8 |
| South-African IMCI modified algorithm for paediatric HIV diagnosis | 20.0 | 94.5 | 8.7 | 97.8 | 3.6 | 0.8 | ||
| Original IMCI algorithm | 9.1 | 96.7 | 8.0 | 97.1 | 2.8 | 0.9 | ||
| Action Against Hunger algorithm | 60.0 | 62.1 | 3.5 | 98.3 | 1.6 | 0.6 | ||
| Presence one or more proxy indicators and MUAC < 110 mm | 95.5 | 54.5 | 7.1 | 99.7 | 2.1 | 0.1 | ||
† PPV = positive predictive value; ‡ NPV = Negative predictive value; § PLR = likelihood ratio for a positive test; & NLR = likelihood ratio for a negative test